- Net profit fell by 17% y-o-y to Rs. 332.2 crore from Rs. 400.5 crore.
- Revenue rose by 2.4% y-o-y to Rs. 4,077.5 crore from Rs. 3,914 crore.
- EBITDA slipped by 13.6% y-o-y to Rs. 707.7 crore from Rs. 818.7 crore.
Cipla spurts after announcing Q3 result
Cipla gained 4.55% to Rs 532 at 15:15 IST on BSE after after the company announced its Q3 December 2018 result during market hours today, 6 February 2019.
Meanwhile, the S&P BSE Sensex was up 350.87 points, or 0.96% to 36,967.68
On the BSE, 3.13 lakh shares were traded in the counter so far compared with average daily volumes of 1.07 lakh shares in the past two weeks. The stock had hit a high of Rs 536 and a low of Rs 504.40 so far during the day.
Cipla’s consolidated profit after tax fell 17% to Rs 332 crore on 2% rise in total revenue from operations to Rs 4008 crore in Q3 December 2018 over Q3 December 2017.
Consolidated earnings before interest, taxes, depreciation and amortization (EBITDA) fell 12% to Rs 720 crore in Q3 December 2018 over Q3 December 2017.
Umang Vohra, MD and Global CEO, Cipla said the company’s US business has delivered strongly in Q3 December 2018 as a result of scale-up of new launches.
Cipla is a global pharmaceutical company focused on agile and sustainable growth, complex generics, and deepening portfolio in home markets of India, South Africa, North America, and key regulated and emerging markets.
⇓ Subscribe with your Email to get daily updates.[jetpack_subscription_form show_only_email_and_button=”true” custom_background_button_color=”#362e77″ custom_text_button_color=”#ffffff” submit_button_text=”Subscribe” submit_button_classes=”wp-block-button__link has-text-color has-white-color has-background has-dark-blue-background-button-color” show_subscribers_total=”false” ]